<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Ai-Regulatory-Impact-Assessment on Bioecon</title><link>https://en.bioecon.ru/technologies/ai-regulatory-impact-assessment/</link><description>Recent content in Ai-Regulatory-Impact-Assessment on Bioecon</description><generator>Hugo</generator><language>en-US</language><lastBuildDate>Tue, 18 Aug 2026 22:19:08 +0700</lastBuildDate><atom:link href="https://en.bioecon.ru/technologies/ai-regulatory-impact-assessment/index.xml" rel="self" type="application/rss+xml"/><item><title>Regulatory-intelligence monitoring platforms</title><link>https://en.bioecon.ru/technology/regulatory-intelligence-monitoring/</link><pubDate>Sun, 16 Aug 2026 08:59:10 +0000</pubDate><guid>https://en.bioecon.ru/technology/regulatory-intelligence-monitoring/</guid><description>Software platforms that continuously monitor global drug and biologics regulatory changes — guidance updates, Candidate List additions, post-approval variation triggers — and use AI to filter and prioritize which changes affect a specific biopharmaceutical product portfolio.</description></item></channel></rss>